| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10908664 | Leukemia Research | 2015 | 20 Pages |
Abstract
These data suggest that YM155-mediated inhibition of Survivin is a potentially beneficial therapeutic strategy for AML, particularly paediatric disease, and warrants further evaluation.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Amanda M. Smith, Erica B. Little, Andjelija Zivanovic, Priscilla Hong, Alfred K.S. Liu, Rachel Burow, Caedyn Stinson, Andrew R. Hallahan, Andrew S. Moore,